InvestorsHub Logo
Followers 125
Posts 8192
Boards Moderated 2
Alias Born 02/20/2006

Re: None

Tuesday, 11/10/2020 5:34:19 AM

Tuesday, November 10, 2020 5:34:19 AM

Post# of 651
BiondVax $BVXV has many possibilities of being merged ... it is the explanation of this great decrease and that it only capitalized $ 27 million, the EU subsidy was already € 25 million of $ 30 million

With this grant, BiondVax built a large vaccine manufacturing plant

BiondVax has a large number of studies and patents thanks to 15 years of research

BiondVax would have to be adduced by some great Biotechnology company such as Pfizer, AstraZeneca, Moderna, Curevac, Janssen, Sanofi and whether to manufacture vaccines against COVI19

I wouldn't be surprised to see BVXV at $ 20 or $ 30
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BVXV News